chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After both doses, I lost my ability to taste seasoned foods, but can taste sweets just fine.; I had mild soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (After both doses, I lost my ability to taste seasoned foods, but can taste sweets just fine.) and VACCINATION SITE PAIN (I had mild soreness at the injection site) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Acid reflux (oesophageal). Concomitant products included FAMOTIDINE for Acid reflux (oesophageal).    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE PAIN (I had mild soreness at the injection site). On an unknown date, the patient experienced TASTE DISORDER (After both doses, I lost my ability to taste seasoned foods, but can taste sweets just fine.). At the time of the report, TASTE DISORDER (After both doses, I lost my ability to taste seasoned foods, but can taste sweets just fine.) and VACCINATION SITE PAIN (I had mild soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.   This case was linked to MOD-2021-333473, MOD-2021-333489.
My symptoms started a few hours after I was vaccinated. I tried to work through my symptoms. Therefore, I became short of breath along with having right side chest discomfort. I began to experience feeling of anxiousness, not able to concentrate on small task. Dizziness became severe days leading up to going into urgent care. I was treated for shortness of breath and given medications called prednisone with a inhaler VENTOLIN HFA.
Few mins after receiving the shot, the pt  started having shooting pain down his hands and numbness that was also extending to his head . Offered to call EMS . But they did not want me to . Asked to go to ER/UC if it does not go away or gets worse . Double checked inj site and it was on the correct spot on his deltoid muscle . He said his mom was also very sensitive this way to certain vaccines
10/29 Felt a little sick but worse as the day went on with: body aches, chills, pain at injection site, fatigue, lack of appetite, flushed cheeks, same feelings on 10/30.  10/31 she developed a cold sore and sores in mouth, ears felt clogged/pressure.  11/1 Still had severe body aches on the injection side.  11/2 feeling better but still out of it.
I received my second booster vaccine on April 8, 2022, on May 19, 2022 I tested positive for Covid-19. I believe I was starting to develop symptoms on Wednesday May 18, 2022, I tested using an at home test and it was negative. Throughout the day, I had a chough and chest tightness, nasal congestion. On Thursday May 19, 2022, I tested positive, I called my primary care physician who called in a prescription of Paxlovid. Yesterday I felt better than I do today, today I have a bit headache and neck tightness and soreness.
pt recv vax 4OCT95 & next day had dulled hearing in lt ear & an audiogram demonstrated a dec in low threshold hearing in that ear;has a nl otoscopic exam & MRI;
Left side of face and tongue experienced numbness. Pharmacist gave me Benadryl to take  at the phamacy and one before bed. Woke up the next morning with full feeling in face.
High fever and head to toe rash. Racing pulse and occasional fast breathing. Joint pain and inconsolable crying with no appetite for 6 weeks...
gallbladder is failing; respiratory issues; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 77 year-old female patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 20Mar2021 (Batch/Lot number: unknown) at the age of 76 years as dose 1, single and administration date 13Jun2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: GALLBLADDER DISORDER (hospitalization) with onset Apr2021, outcome "not recovered", described as "gallbladder is failing"; RESPIRATORY SYMPTOM (hospitalization) with onset 2021, outcome "unknown", described as "respiratory issues". Therapeutic measures were not taken as a result of gallbladder disorder, respiratory symptom.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Pt felt warm and flushed, as well as, anxious. Hx of HTN, vitals were taken. BP of 210/100. HR 75, spO2 97%. Pt was asked to lie down, and remove extra jacket layer since he felt warm and diaphoretic. Pt drank water, second BP was lower 165/80. Pt advised to go see cardiologist. Followed up with patient after leaving facility. Pt medication regime was altered by cardiologist, stable.
she had tingling in her hands and legs; This is a spontaneous report from a contactable Nurse from medical information team.  A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PARAESTHESIA (non-serious), outcome "unknown", described as "she had tingling in her hands and legs". Additional information: this nurse referred the patient to a chiropractor thinking it was unrelated to the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the available information, there is a reasonable possibility of a causal relationship between the suspect vaccine BNT162B2 (COMIRNATY) and reported event paresthesia which cannot be fully assessed/excluded. The case will be reassessed if additional information becomes available.
Flushing (Chest and face) - gave 25mg PO diphenhydramine and sent her to the Emergency room for further care.
>Sore arm - Days 1 to 2 - Resolved without intervention >Gas/Diarrhea - Days 1 to 7 - Resolved without intervention >Engorged breasts - Days 3 to 5 - Resolved without intervention >Sore/uncomfortable (lump) under arm - Days 3 to 7 - Mostly resolved (no current intervention) >Red raised rash (nickle-sized and about 5 inches below injection site)  - Days 8 to 9 - Mostly resolved (no current intervention)
chills .; body ache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 04Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose), for Covid-19 immunization. The following information was reported: CHILLS (non-serious) with onset 04Mar2021, outcome "unknown", described as "chills ."; PAIN (non-serious) with onset 04Mar2021, outcome "unknown", described as "body ache".  Additional information: The patient was querying if Tylenol can be taken for the events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Mom called at 18:00 on 8/1/01 to report that her child had had hives on face for approx. 2 hours.
He has no energy, slept all night. No strength; Felt ill; Night Sweats; Weak and Fatigue; Symptoms similar to when he had COVID-19; Weak and Fatigue; Sweating; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (Symptoms similar to when he had COVID-19), ASTHENIA (Weak and Fatigue), HYPERHIDROSIS (Sweating), ASTHENIA (He has no energy, slept all night. No strength) and MALAISE (Felt ill) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced HYPERHIDROSIS (Sweating). On 23-Mar-2021, the patient experienced SUSPECTED COVID-19 (Symptoms similar to when he had COVID-19), ASTHENIA (Weak and Fatigue), ASTHENIA (He has no energy, slept all night. No strength), MALAISE (Felt ill), NIGHT SWEATS (Night Sweats) and FATIGUE (Weak and Fatigue). At the time of the report, SUSPECTED COVID-19 (Symptoms similar to when he had COVID-19), ASTHENIA (Weak and Fatigue), HYPERHIDROSIS (Sweating), ASTHENIA (He has no energy, slept all night. No strength), MALAISE (Felt ill), NIGHT SWEATS (Night Sweats) and FATIGUE (Weak and Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided; Sender's Comments:  MOD21-062247:Crosslink
Migraine, muscle aches, fever and chills. Treated with Tylenol. All symptoms resolved within 36-40 hours.
Flu like symptoms, sweating , nausea, body aches, Tachycardia, dizzyness, severe pain in injection site, cramping in pelvic area , I was pregnant, admitted into hospital in the evening and kept overnight.
Sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021422152 (pfizer).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "She has a Hx of pain" (unspecified if ongoing), notes: (unclear where) and takes pain medication for it. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: First, Lot no: Unknown), administration date: 22Mar2021, for Covid-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Sore arm".  Additional information: Patient reports she is feeling fine after receiving the second shot other than waking up this morning (as reported) with a sore arm. States the pain is not bad at all.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Swelling left knee, pain shoulders,hips, and bullocks, neck Using prednisone and Celebrex
on April 22, I woke up with inflammation in my throat, eyes and face. I had urticaria developing all over my body. I immediately contacted my PCP which instructed me to start a methylPREDNISolone 4 mg tablet dose pack, antihistamine, and to keep my daughter's Epipen close. Then series of  bloodwork was pulled on me on April 26 beginning with food allergy. I was placed on Xyzal, Atarax, and a   a week of Prednisone. It was negative but they referred me to an allergist for further testing. It was negative but he started me on Singular, another round of steroids, and injection of Xolair 300mg. Then I was referred to a dermatologist for a  left posterior thigh punch Biopsy.  The diagnosis came back of urticaria or urticarial vasculities which I was placed on 60mg of Predisone. I had more bloodwork taken. Then I was referred to a rheumatologist since the biopsy suggested that an interstitial drug eruption, prevasculitic leukocystoclastic vasculitis and neutrophilic dermatitis associated with rheumatoid arthritis cannot be ruled out.  She started me on on Planquenil 200mg daily.  At this point, we don't have a timeframe but all doctors have pulled a ton of bloodwork to backup all of these findings.
pt started getting a fever @ 1PM the same day as vax;pt had swelling @ the site of DTP as well as soreness;pt was very cranky & was sore for 3 days following vax;3rd day pt died;
I have pain in my neck, my left arm and now it's going down my left leg it's numb now; I have pain in my neck, my left arm and now it's going down my left leg it's numb now; I have pain in my neck, my left arm and now it's going down my left leg it's numb now; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NECK PAIN (non-serious), PAIN IN EXTREMITY (non-serious), HYPOAESTHESIA (non-serious), outcome "unknown" and all described as "I have pain in my neck, my left arm and now it's going down my left leg it's numb now".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Acute GI bleed, hematemesis 3/28 occurred 1 hour after 2nd COVID-19 vaccine
Pt w/ presumed influenza given PNEUMOVAX 10/20/09. Also on TAMIFLU.
Patient given a dose of Moderna 1 day past its BUD. No reported issues from patient. Moderna stated no need for revaccination.
seizure; This spontaneous report was received from a consumer, a father calling on behalf of the daughter: an 8-month-old female patient. Information regarding the patient's concurrent conditions, medical history, historical drugs and concomitant therapies was not provided.  On 10-MAR-2021, the patient was vaccinated with the third dose in the three-dose series of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # 1661010, expiration date not reported but upon internal validation established as 29-MAY-2021, oral for prophylaxis (strength, dose, vaccination scheme frequency were not reported), along with pneumococcal 4 6b 9v 14 18c 19f 23f conj vaccine (crm197) (PREVNAR) and hib conj vaccine (tet toxoid), diphtheria toxoid, pertussis acellular 5-component vaccine, poliovirus vaccine inactivated (mrc-5), tetanus toxoid (PENTACEL) (formulation, strength, dose, frequency, route of administration, indication, lot number and expiration date were not reported).      On the morning of 11-MAR-2021, the patient was hospitalized due to seizures. The patient received the anti-seizure medications acetaminophen (TEMPRA) and phenobarbital. The father reported that there was no reaction to the first two doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), and the daughter had no known allergies. The lot numbers for the first and second doses were 1691132 (expiration date not reported but upon internal validation established as 30-NOV-2021) and 1687009 (expiration date not reported but upon internal validation established as 28-JUN-2021) respectively. The outcome of the seizures was reported as recovered.  The reporter considered the seizures to be related to rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ). The causal relationship between the seizures and pneumococcal 4 6b 9v 14 18c 19f 23f conj vaccine (crm197) (PREVNAR) and hib conj vaccine (tet toxoid), diphtheria toxoid, pertussis acellular 5-component vaccine, poliovirus vaccine inactivated (mrc-5), tetanus toxoid (PENTACEL) was not reported.   Upon internal review, the seizures were determined to be medically significant.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. No information on their medical history, concurrent conditions or concomitant drugs was provided. On 06-AUG-2014 the patient was vaccinated with an expired dose of RECOMBIVAX HB 5/0.5 mcg/ml, 0.5ml administered intramuscularly; lot # 0737AE, expiration date 18-APR-2014; site of administration unkonwn. This was patient's third dose of RECOMBIVAX HB; dates of the two previous vaccinations were not reported. The patient experienced no adverse effects. Additional information has been requested.
Pregnant; Sore arm; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 27-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (2 to 3 drinks a week) in August 2020. Concurrent medical conditions included Anxiety (Stable and under control now) and Acid reflux (oesophageal). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and CALCIUM CARBONATE (TUMS ANTACID) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 07-Sep-2020 and the estimated date of delivery was 14-Jun-2021. On 24-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-fourth week of the pregnancy.  On 24-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Oct-2020, Pregnancy test: positive (Positive) Positive. On an unknown date, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On an unknown date, ultrasound was performed to check anatomy which came normal, genetic test (to check for spina bisida) was low risk and down syndrome test was at low risk. The estimated date of conception was 28 Sep 2020. She was 24 weeks and 3 days.  Treatment information was not reported
Narrative:  Admitted to hospital, icu admission for Pulmonary embolism. Presented with shortness of breath after his second covid shot.
Patient called the pharmacy about 2pm today and states she has a fever 101 degree Fahrenheit, nausea, vomiting, body aches, headache, chills. Says she took TYLENOL to help.
This spontaneous report has been received from an athletic trainer referring to a patient of unknown age and gender during follow-up contact with an office. A nurse had initially called to report a temperature excursion but reported that there was no adverse event. Concomitant medication included sterile diluent. Information about pertinent medical history and drug reactions/allergies was not provided. On 21-FEB-2019, the patient was vaccinated with one dose of improperly stored VARIVAX lot # R006752, expiration date 06-MAR-2020 for prophylaxis (dose detail, anatomical location and route of administration were not reported). The concomitant medication sterile diluent used to reconstitute VARIVAX was properly stored. No symptoms reported. The vaccine was exposed to temperature excursion below minus 10 degree Celsius for a time frame of less than 24 hours without previous temperature excursion. The athletic trainer did not know the exact time frame. Data logger was not involved.
Redness and swelling at injection site 48 hours after and continuing for several days; itching at site beginning 48 hours after and continuing to present; total body aches, sore throat, and fogginess 24 hours after and clearing up within 48 hours
Presented to ER with subacute malaise and worsening bruising area receiving Johnson & Johnson COVID vaccine 11 days ago, found to have microangiopathic hemolytic anemia and thrombocytopenia, concerning for TTP. He was transferred to Hospital as a direct admit to initiate plasmapheresis. Patient outcome tentative.
within 10 minutes of injection reported throat tingling and asked for diphenhydramine.  reported she normally takes diphenydramine prior to influenza vaccination but did not share any previous reactions to influenza vaccination.  observed x30 minutes with no further issues.  BP WNL, no SOB, no swelling.  at 30 minutes was informed that COVID vaccine did not have any components related to influenza vaccine and fell much better and discharged.
Feeling aches, hip, head; Chills; Lost my appetite; Night sweats; This is a spontaneous report from a contactable consumer (the patient).   A 73-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Right on 24May2021 09:15 (at the age of 73-year-old), as dose 1, single for covid-19 immunization. Medical history included Shellfish allergy, covid-19 (If covid prior vaccination: Yes). Concomitant medications included ramipril (ALTACE), simvastatin, and omeprazole, HRT. Patient did not receive any other vaccine in four weeks. The patient previously took neosporin (bacitracin,neomycin sulfate,polymyxin b sulfate) and experienced drug hypersensitivity, polysporin (bacitracin zinc,neomycin sulfate,polymyxin b sulfate) and experienced drug hypersensitivity. Patient had not tested for covid post vaccination. At about 7pm the evening of the day (24May2021) patient got the shot at 9:15AM, she started feeling aches, hip, head. She also had chills. She lost her appetite for the next three days and continued to have aches pains and night sweats. Her sheets were soaked wet each morning. Adverse events resulted in Doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment. All events resolved on an unknown date.  Information about lot/batch number has been requested.
Client received Moderna vaccine for dose number 1, inadvertently given Pfizer vaccine for dose #2.  Client aware of vaccine error.
Pt. reports to this clinic observe increased swelling at the injection site, noted approx. nickel size redness/swelling warm to touch. Instructed pt. to take ibuprofen or another anti-inflammatory, also can apply cool pack she had only did this, 20 minutes at a time. Also explain can use hydrocortisone cream or topical BENADRYL topically.
Patient was seen to get the first shot in the covid series. She received a booster of pfizer bivalent instead. Patient noticed while in the waiting room during the 15 min. Also received a flu vaccine in her right arm at the time.
Immediately after receiving vaccine, she felt pain in her left deltoid, followed by a spasm in her left trapezius, and headache. She experienced a warm sensation travelling down her left arm. She described a feeling of muscle spasms in her left upper and lower extremity and was unable to bear weight on her left lower extremity due to the altered sensation. She endorsed acute nausea and vomiting. She was transferred from vaccine clinic to emergency department at 1420.  Patient received diphenydramine 12.5mg IV @ 1722, prochlorperazine 10mg IV @1733, Lactated Ringers 250mL IV bolus @ 1733, ondansetron ODT 4mg  @1445. Patient was diagnosed with an acute anxiety attack in the setting of a novel vaccine administration.  She was discharged at 1854.
Patient felt pain in her back on 6/10/09. Patient didn't realize that she had a rash till 6/14/09. The rash was approx. 6" in diameter in a circular pattern. Patient saw Dr. on 6/16 who Dx. as shingles and wrote Rx for VALTREX 1gm TID x 7 days. Rash is down to 3" diameter.